Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cross

Showing results (1-10 of 313) with videos related to

Pageof 32
Sort By:
Inflammatory Bowel Diseases|September 15, 2017
Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative ColitisRaymond K Cross
Public Health Reports (Washington, D.C. : 1974)|March 1, 1984
Changes in rates of spontaneous fetal deaths reported in Upstate New York vital records by gestational age, 1968-78P K Cross
Virology|October 30, 1983
Identification of a unique guanine-7-methyltransferase in Semliki Forest virus (SFV) infected cell extractsR K Cross
Expert Review of Gastroenterology & Hepatology|April 28, 2015
Which patients with inflammatory bowel disease should receive combination therapy?Raymond K Cross
The American Journal of Gastroenterology|June 28, 2018
Is There a Role for Thiopurines in IBD?Raymond K Cross, Hans Herfarth
Inflammatory Bowel Diseases|July 6, 2016
Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and DifferencesAnita Afzali, Raymond K Cross
Clinical Trials (London, England)|October 14, 2009
Challenges in the design of a Home Telemanagement trial for patients with ulcerative colitisRaymond K Cross, Joseph Finkelstein
Drug Design, Development and Therapy|February 7, 2023
Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported OutcomesSara Horst, Raymond K Cross
Expert Opinion on Drug Safety|July 4, 2015
Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitisMatilda Hagan, Raymond K Cross
Digestive Diseases and Sciences|January 11, 2007
Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot studyRaymond K Cross, Joseph Finkelstein
Pageof 32

Showing results (1-10 of 313) with videos related to

Sort By:
Pageof 32
Inflammatory Bowel Diseases|September 15, 2017
Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative ColitisRaymond K Cross
Public Health Reports (Washington, D.C. : 1974)|March 1, 1984
Changes in rates of spontaneous fetal deaths reported in Upstate New York vital records by gestational age, 1968-78P K Cross
Virology|October 30, 1983
Identification of a unique guanine-7-methyltransferase in Semliki Forest virus (SFV) infected cell extractsR K Cross
Expert Review of Gastroenterology & Hepatology|April 28, 2015
Which patients with inflammatory bowel disease should receive combination therapy?Raymond K Cross
The American Journal of Gastroenterology|June 28, 2018
Is There a Role for Thiopurines in IBD?Raymond K Cross, Hans Herfarth
Inflammatory Bowel Diseases|July 6, 2016
Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and DifferencesAnita Afzali, Raymond K Cross
Clinical Trials (London, England)|October 14, 2009
Challenges in the design of a Home Telemanagement trial for patients with ulcerative colitisRaymond K Cross, Joseph Finkelstein
Drug Design, Development and Therapy|February 7, 2023
Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported OutcomesSara Horst, Raymond K Cross
Expert Opinion on Drug Safety|July 4, 2015
Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitisMatilda Hagan, Raymond K Cross
Digestive Diseases and Sciences|January 11, 2007
Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot studyRaymond K Cross, Joseph Finkelstein
Pageof 32